Search

everythinglearnresearchcommunity

for

Search:↓

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

TNF-alpha inhibitors can cause various immune-related skin issues.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Some drugs used to treat inflammation may cause hair loss.

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

Older patients sticking to their prostate medication saw lasting health benefits.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Finasteride improves heart function in obese and aging male rats by reducing oxidative stress and p53 protein levels.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Some drugs used to treat immune conditions may cause different types of hair loss.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Adalimumab helped control a child's severe eye disease when other treatments failed.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Finasteride improves urinary function in men for 2 years.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Women experience more side effects and have worse blood pressure control from hypertension treatments than men, despite using different medications.